Company Profiles

driven by the PitchBook Platform

Koronis Pharmaceuticals

Koronis Pharmaceuticals
1998 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of anti-viral therapeutics designed to treat hepatitis C and AIDS. The company's anti-viral therapeutics are based on a novel mechanism, Viral Decay Acceleration (VDA) and offers KP-1461 for the treatment of AIDS/human immunodeficiency virus, enabling patients to discover faster from such deadly diseases and reduces complications and medicinal side-effects.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Acquirer
Pacific Horizon Ventures
Primary Office
500 Union Street
Suite 835
Seattle, WA 98101
United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Koronis Pharmaceuticals’s full profile, request a free trial.

Koronis Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 0000 Completed Profitable
7. Angel (individual) 01-Jan-2015 0000 Completed Profitable
6. Later Stage VC 09-Jan-2012 000 0000 Completed Profitable
5. Later Stage VC (Series E) 01-Aug-2008 000 0000 000.00 Completed Profitable
4. Later Stage VC (Series D) 28-Jun-2007 0000 0000 000.00 Completed Profitable
3. Later Stage VC (Series C) 01-Jun-2005 0000 0000 000.00 Completed Profitable
2. Early Stage VC (Series B) 04-Jan-2002 $10M $11M Completed Profitable
1. Early Stage VC (Series A) 15-Jun-2001 $1M $1M Completed Profitable
To view this company’s complete deal history including valuation and funding, request access »

Koronis Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series B2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B1 00,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series B 36,197 $0.001000 $7.15 $89.39 $41.84 0x $49.16 0.09%
Series A 5,500 $0.001000 $8 $100 $46.81 0x $66.67 0.01%
To view this company’s complete Cap Table, request access »

Koronis Pharmaceuticals Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
AmorChem Venture Capital Minority 000 0000 000000 0
Asset Management Ventures Venture Capital Minority 000 0000 000000 0
VA Angels Angel Group Minority 000 0000 000000 0

Koronis Pharmaceuticals Executive Team (5)

Name Title Board
Seat
Contact
Info
John Reno Chief Operating Officer

4 Former Executives

You’re viewing 1 of 5 executives. Get the full list »

Koronis Pharmaceuticals Board Members (4)

Name Representing Role Since Contact
Info
Donald Elmer Pacific Horizon Ventures Chairman 000 0000

3 Former Board Members

You’re viewing 1 of 4 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com